|
|
||||||||
Clinical Trial |
Quality of life measures are increasingly used as important efficacy endpoints in studies of drugs for asthma. The purpose of this study was to assess both the sensitivity to change and the construct validity of four different quality of life instruments in patients with asthma. In a double-blind, parallel group study, 120 moderate asthma patients, aged between 18-70 yrs, received either inhaled salmeterol 50 micrograms b.i.d. or inhaled salbutamol 400 micrograms b.i.d. In addition to respiratory outcomes, quality of life was measured at a 6 weeks follow-up using: 1) Asthma Quality of Life Questionnaire (AQLQ); 2) Living With Asthma Questionnaire (LWAQ); 3) Sickness Impact Profile (SIP); 4) Rating Scale (RS); and Standard Gamble (SG) utilities. Salmeterol led to significant improvements over salbutamol on virtually all clinical outcomes. Although all the quality of life instruments showed the same trend in favour of salmeterol, only the AQLQ and RS utilities showed significantly greater improvement on salmeterol than on salbutamol. Except for the AQLQ, the correlation between change in lung function and change in quality of life was generally low. Whereas, the AQLQ correlated well with the patient's overall assessment of efficacy (r = 0.64), the LWAQ, SIP and utilities failed to show such a correlation. The AQLQ showed the best correlation with symptom scores. The cross-sectional correlation between the AQLQ and the LWAQ was 0.73, whereas the longitudinal correlation was only 0.29. The SG generally showed poor correlation with other measures, including the RS. In conclusion, patients given salmeterol showed a greater improvement in quality of life compared to patients given salbutamol. Of the disease-specific questionnaires the Asthma Quality of Life Questionnaire was found to be more responsive to change than the Living With Asthma Questionnaire and showed greater validity. Of the generic instruments, the rating scale utilities were most responsive. The Standard Gamble showed poor correlation with other measures.
This article has been cited by other articles:
![]() |
M. O. Edelen, M. A. Burnam, K. E. Watkins, J. J. Escarce, H. Huskamp, H. H. Goldman, and G. Rachelefsky Obtaining Utility Estimates of the Health Value of Commonly Prescribed Treatments for Asthma and Depression Med Decis Making, September 1, 2008; 28(5): 732 - 750. [Abstract] [PDF] |
||||
![]() |
M. G Pearson Breathing exercises for asthma: panacea or placebo? Thorax, December 1, 2007; 62(12): 1033 - 1034. [Full Text] [PDF] |
||||
![]() |
S. Ferrero, P. Petrera, B.M. Colombo, R. Navaratnarajah, M. Parisi, P. Anserini, V. Remorgida, and N. Ragni Asthma in women with endometriosis Hum. Reprod., December 1, 2005; 20(12): 3514 - 3517. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. M. Ross, T. M. A. Davis, and G. F. Macdonald Cognitive-Behavioral Treatment Combined With Asthma Education for Adults With Asthma and Coexisting Panic Disorder Clin Nurs Res, May 1, 2005; 14(2): 131 - 157. [Abstract] [PDF] |
||||
![]() |
M. Albers, T. Schermer, G. van den Boom, R. Akkermans, C. van Schayck, C. van Herwaarden, and C. van Weel Efficacy of Inhaled Steroids in Undiagnosed Subjects at High Risk for COPD: Results of the Detection, Intervention, and Monitoring of COPD and Asthma Program Chest, December 1, 2004; 126(6): 1815 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.F. Juniper, M.E. Wisniewski, F.M. Cox, A.H. Emmett, K.E. Nielsen, and P.M. O'Byrne Relationship between quality of life and clinical status in asthma: a factor analysis Eur. Respir. J., February 1, 2004; 23(2): 287 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Schermer, B. P. Thoonen, G. van den Boom, R. P. Akkermans, R. P. Grol, H. T. Folgering, C. van Weel, and C. P. van Schayck Randomized Controlled Economic Evaluation of Asthma Self-Management in Primary Health Care Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1062 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oga, K. Nishimura, M. Tsukino, S. Sato, T. Hajiro, and M. Mishima Comparison of the Responsiveness of Different Disease-Specific Health Status Measures in Patients With Asthma Chest, October 1, 2002; 122(4): 1228 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.D. Bateman, L.F. Frith, and G.L. Braunstein Achieving guideline-based asthma control: does the patient benefit? Eur. Respir. J., September 1, 2002; 20(3): 588 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.W. Jones Interpreting thresholds for a clinically significant change in health status in asthma and COPD Eur. Respir. J., March 1, 2002; 19(3): 398 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. VAN DEN BOOM, M. P. M. H. RUTTEN-VAN MOLKEN, J. MOLEMA, P. R. S. TIRIMANNA, C. VAN WEEL, and C. P. VAN SCHAYCK The Cost Effectiveness of Early Treatment with Fluticasone Propionate 250 {micro}g Twice a Day in Subjects with Obstructive Airway Disease . Results of the DIMCA Program Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2057 - 2066. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.F. Juniper, G.R. Norman, F.M. Cox, and J.N. Roberts Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma Eur. Respir. J., July 1, 2001; 18(1): 38 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. MOY, E. ISRAEL, S. T. WEISS, E. F. JUNIPER, L. DUBÉ, J. M. DRAZEN, and the NHLBI Asthma Clinical Rese Clinical Predictors of Health-related Quality of Life Depend on Asthma Severity Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 924 - 929. [Abstract] [Full Text] |
||||
![]() |
L M Osman, L McKenzie, J Cairns, J A R Friend, D J Godden, J S Legge, and J G Douglas Patient weighting of importance of asthma symptoms Thorax, February 1, 2001; 56(2): 138 - 142. [Abstract] [Full Text] |
||||
![]() |
H Moudgil, T Marshall, and D Honeybourne Asthma education and quality of life in the community: a randomised controlled study to evaluate the impact on white European and Indian subcontinent ethnic groups from socioeconomically deprived areas in Birmingham, UK Thorax, March 1, 2000; 55(3): 177 - 183. [Abstract] [Full Text] |
||||
![]() |
L. M. OSMAN, C. CALDER, R. ROBERTSON, J. A. R. FRIEND, J. S. LEGGE, and J. GRAHAM DOUGLAS Symptoms, Quality of Life, and Health Service Contact among Young Adults with Mild Asthma Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 498 - 503. [Abstract] [Full Text] |
||||
![]() |
E. F. Juniper and A. S. Buist Health-Related Quality of Life in Moderate Asthma: 400 {micro}g Hydrofluoroalkane Beclomethasone Dipropionate vs 800 {micro}g Chlorofluorocarbon Beclomethasone Dipropionate Chest, November 1, 1999; 116(5): 1297 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A.E. Nickerson Assessing Convergent Validity of Health-state Utilities Obtained Using Different Scaling Methods Med Decis Making, October 1, 1999; 19(4): 487 - 498. [Abstract] [PDF] |
||||
![]() |
E. F. Juniper, A. S. Buist, F. M. Cox, P. J. Ferrie, and D. R. King Validation of a Standardized Version of the Asthma Quality of Life Questionnaire Chest, May 1, 1999; 115(5): 1265 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Bentsen, B. Natvig, and M. Winnem Questions you didn't ask? COOP/WONCA Charts in clinical work and research Fam. Pract., April 1, 1999; 16(2): 190 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Lockey, L. M. DuBuske, B. Friedman, V. Petrocella, F. Cox, and K. Rickard Nocturnal Asthma: Effect of Salmeterol on Quality of Life and Clinical Outcomes Chest, March 1, 1999; 115(3): 666 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. LEIDY, K. S. CHAN, and C. COUGHLIN Is the Asthma Quality of Life Questionnaire a Useful Measure for Low-income Asthmatics? Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1082 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Nanda and E. M. Andresen Health-Related Quality of Life: A Guide for the Health Professional Eval Health Prof, June 1, 1998; 21(2): 179 - 215. [Abstract] [PDF] |
||||
![]() |
J. R. CURTIS, D. P. MARTIN, and T. R. MARTIN Patient-assessed Health Outcomes in Chronic Lung Disease . What are They, How Do They Help Us, and Where Do We Go From Here? Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1032 - 1039. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |